Blood Weekly articles from June 2002

Blood Weekly archives from June 2002

COPP chemotherapy may prevent later hematological cancers.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A widely used cytoxin-based chemotherapy regimen for children with Hodgkin disease may help prevent future hematological cancers, according to researchers in...

Tax protein-induced drug resistance mediated by surprising agent.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have shed new light on the mechanisms of drug resistance conferred by the leukemic Tax protein. Dr. Yoshimune Sakaki and colleagues...

Microenvironment rules angiogenesis in hematological cancer.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new report lends additional support to increasing evidence of angiogenic mechanisms in acute myeloid leukemia (AML) although previous studies diverge on where...

New radioimmunotherapy drug proves highly effective.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- A Mayo Clinic study indicates the first of a new class of drugs involving radioimmunotherapy benefited a significant number of patients with low-grade B cell non-Hodgkin lymphoma who have exhausted...

Hematopoietic muscle cells originate in bone marrow.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A simple explanation may exist for mysterious hematopoietic stem cells found in muscle, researchers in the United States say. "The nature of cells...

Iron depletion can reverse cirrhosis in some patients given marrow transplants.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Cirrhosis reversal may be possible for patients with thalassemia major who are cured after receiving bone marrow transplantations. Thalassemia, a condition...

Hematopoietic stem cells may help mediate atherosclerosis.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cells may contribute to the development of atherosclerosis and other vascular dysfunction, researchers in Japan report. "Excessive...

U.S. FTC approves global agreement signed by Isotechnika and Roche.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Joseph Koziak, executive vice president of Isotechnika, Inc., reported that the United States Federal Trade Commission has approved the agreement for the global codevelopment of Isotechnika's transplant...

Monotherapy study results on Vevesca (OGT 918) presented at EWGGD.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Oxford GlycoSciences, Plc, reported that a 36-month update on the OGT 918-001 monotherapy study data was presented at the 5th European Working Group on Gaucher Disease meeting in Prague. Data were...

Studies: CellCept benefits patients reinfected with after liver transplant.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- The immunosuppressive drug CellCept (mycophenolate mofetil) positively altered the course of hepatitis C reinfection after liver transplantations in three investigational studies reported at the...

Fertility affected in long-term survivors.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Long-term survivors of childhood leukemia suffer from infertility problems later in life, according to a study presented at the 2002 Pediatric Academic Societies meeting in Baltimore, Maryland. ...

Campath offers new survival hope for patients with advanced B-CLL.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Life expectancy of heavily pretreated leukemia (B-CLL) patients doubled from 8 to 16 months in the pivotal clinical trial that led to FDA approval of alemtuzumab (Campath), according to lead author...

Women at highest risk less likely to be screened than those at lower risk.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Women at highest risk for ovarian cancer receive less screening and report less worry about getting the disease than women with a lower yet somewhat elevated risk, according to researchers at the Fred...

Ganciclovir effective as human herpersvirus 6 prophylaxis.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antiviral agent ganciclovir (GCV) can be effectively used to prevent human herpersvirus-6 activation after stem cell transplants, researchers in Japan...

Warning issued over type of blood plasma; six liver transplant patients dead in Los Angeles.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- A company that manufactures a form of blood plasma issued a warning years after six liver transplant patients who received the plasma died. Six of 31 or 32 liver transplant patients at Cedars-Sinai...

Prograf plus rapamycin: Combined use safe and effective.
June 6, 2002... 2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Prograf (tacrolimus) can be used safely in combination with the new, adjunctive immunosuppressant, rapamycin, according to results announced at the American Transplant Congress meeting . ...

Bovine hemoglobin superior to human hemoglobin for oxygen carriers.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Bovine hemoglobin (BHb) is a promising alternative to human hemoglobin for use in artificial oxygen carrier substances, researchers in Japan say. ...

Unbound iron in some blood products may increase infection risk.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Some blood products carry heightened levels of unbound iron shortly after donation, which can increase the risk of infectious diseases for recipients of these...

Reduced-intensity stem cell transplant conditioning regimen effective.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan say that a reduced-intensity, cladrabine-based conditioning regimen can improve outcomes for leukemia and lymphoma patients undergoing...

Natural killer cell mutations can affect outcome.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in France have identified another prognostic factor for finding patients at high risk for complications after stem cell transplantation. ...

Delicate balancing act needed when using gene therapy to treat limb ischemia.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Though studies have shown gene therapy incorporating genetic coding for angiogenic growth factors can be effective for treating critical limb ischemia, there...

Patients with advanced B-CLL double life expectancy in clinical trial.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Life expectancy for patients with B cell chronic lymphocytic leukemia (B-CLL) doubled from eight to 16 months in a worldwide clinical trial of alemtuzumab (CampathR), according to lead researcher Dr....

Cancer drug proves effective therapy.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Illinois at Chicago College of Medicine have demonstrated that a drug long used to treat cancer is also effective in combating sickle cell disease. The drug,...

Both infections associated with reduced (gamma) (delta) T-cell counts.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Patients infected with tuberculosis, HIV, or both carry reduced levels of an important T-cell subset, researchers report. "Several recent studies suggest...

Huntleigh Healthcare announces contract with Premier.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Huntleigh Healthcare, Inc., is pleased to announce a new 42-month contract with Premier, Inc., effective June 1, 2002. The dual source agreement covers Huntleigh's line of Intermittent Pneumatic...

Patient's own blood cells may help deliver cure.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- A patient's own red blood cells may be used to deliver drugs and gene therapy, new research reveals in the June 2002 genome medicine issue of Gene Therapy. Researchers hope to treat many diseases...

Hema Metrics signs exclusive distribution agreement with Baxter Canada.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Hema Metrics announced the recent signing of an exclusive distribution agreement for the Crit-Line device with Baxter Canada. The Crit-Line enables the real-time continuous measurement of absolute...

First clinical data presented on latest technological advance in therapy.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- The first recombinant Factor VIII therapy for hemophilia A prepared entirely without the use of human- or animal-derived additives was found to be bioequivalent to the current gold-standard recombinant...

Global Factor VIII supply to improve following EC approval of facilities.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that its recombinant factor VIII production facilities in St. Louis, Missouri, and Algete, Spain, have both received approval from the...

Low platelet counts during exanthem subitum linked to bone marrow suppression.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have shed new light on the factors underlying the low platelet levels often seen in infants suffering from roseola. Dr. Hiroyuki...

Jefferson scientists create first animal model of common type of leukemia.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have developed the first animal model of the most common type of human leukemia. ...

Genetic discovery in fruit flies may open new avenues for understanding cancer growth in humans.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Fred Hutchinson Cancer Research Center scientists report a finding in the common fruit fly that may open new paths for understanding some of the key genetic missteps that lead to cancer in humans. The...

Knockout blood protein drug signals possible new treatment for Alzheimer and diabetes.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Scientists at the University College London (UCL) have developed a drug to treat a serious medical condition linked to Alzheimer disease and type 2 diabetes. The research, supported by the Medical...

Link found between Fanconi anemia and ataxia telangiectasia.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Fanconi anemia (FA) is an inherited genetic disorder characterized by birth defects, progressive bone marrow failure and an extremely high risk of developing leukemia or other forms of cancer. ...

PAHO, Red Cross unite to fight disease, child deaths.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- The Pan American Health Organization (PAHO) signed a landmark agreement with the International Federation of the Red Cross (IFRC) on May 15, 2002, to work together to reduce childhood deaths, fight...

Stem cell transduction via retroviral vectors ignites transgene persistence.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a unique in vivo approach for delivering genes with murine retroviral vectors, scientists at the University of Nevada have stimulated transgenic...

Higher filgrastim doses increase stem cell yield, toxicity risk.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - High doses of granulocyte colony-stimulating factor (G-CSF) provide more efficient mobilization of stem cells for transplantation, but can increase patient...

Positive selection effective for autologous grafts from neuroblastoma patients.
June 13, 2002... 2002 JUN 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Positive selection is a suitable purging technique for use with autologous stem cell grafts taken from children suffering from neuroblastoma, researchers say....

Dose intensification with stem cell autografts effective for high-risk patients.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Intensive second-line chemotherapy combined with autologous stem cell transplantation is an effective treatment for patients suffering from high-risk Hodgkin...

Drug blocks gene mutation effect in lethal leukemia.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- A new drug blocks the impact of a cancer-causing gene mutation found in a common and lethal form of leukemia, say researchers at the Johns Hopkins Kimmel Cancer Center. Their findings in animal...

Tetra-arsenic tetra-sulfide safe, effective.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Tetra-arsenic tetra-sulfide (As[subscript]4S[subscript]4) shows promise for the treatment of patients suffering from acute promyelocytic leukemia (APL),...

Interleukin-18 plays key role in host defense.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in India and Japan have identified a cytokine playing a key role in the body's immune response to malaria. Ram Pyare Singh and colleagues at...

UF researchers discover blood stem cells can make new blood vessels in mice.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Stem cells found in the bone marrow of adult mice don't just evolve into key components of blood - they are able to build blood vessels. The discovery, announced May 31, 2002, by University of Florida...

Scientists unlock mechanism for recovering autologous adult bone marrow stem cells.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Scientists from Weill Medical College of Cornell University have discovered the mechanism by which a renewable source of autologous organ-specific adult bone marrow stem cells may be recruited. ...

Stem cell transplantation feasible after arsenic trioxide therapy.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cell transplantation is feasible for acute promyelocytic leukemia patients treated with arsenic trioxide, researchers in Italy report. ...

Interleukin-12 blocks stem cell eosinophil differentiation.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the mechanisms by which the cytokine interleukin (IL)-12 relieves the symptoms of asthma. ...

LifeSource Blood Services implements IDM's Surround 3.0.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- LifeSource Blood Services announced that it has implemented Information Data Management, Inc.'s (IDM) "Surround Lite System" to manage and transmit donor serology test results to one of their testing...

BioErgonomics patents method for detection of binding pair complexes.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- St. Paul, Minnesota-based BioErgonomics, Inc., (BioE) has received a patent for technology that makes detection and identification of diseases such as hepatitis C and HIV possible at a much earlier...

Hemostatometry useful for tracking hemostasis during surgery.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hemostatometers can give heart surgeons early warning of developing coagulopathic states in their patients, researchers in the United States find. "A...

Celebrated idea for curing cancer proves hard to translate from mouse to man.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Dr. Judah Folkman's mice are growing old and gray, famously cured of cancer. But people? Not yet and probably not real soon. Developing new cancer treatments is a notoriously frustrating...

Cord blood immune cells can prevent infection.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Under the right circumstances, immune cells in umbilical cord blood are capable of fighting off oncogenic Epstein-Barr virus infection, researchers in the...

Alliance Pharmaceutical Corp. announces third quarter financial results.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) reported a net loss of $6.2 million, or $0.36 per share, for its third fiscal quarter ended March 31, 2002, compared with a net loss of $17.2 million, or $1.74 per...

Rockwell Medical reports 8.7% increase in first quarter sales.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Rockwell Medical Technologies, Inc., (RMTI) a hemodialysis concentrate manufacturer, reported that first quarter 2002 revenue was $2,445,330, an increase of 8.7% over the first quarter of 2001. ...

Emisphere reports results from phase III oral heparin trial.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS), announced initial results from its phase III study with an oral heparin formulation for the prevention of deep vein thrombosis (DVT, or blood clots) in total hip...

Interleukin-12 mediates human T-lymphotropic virus-induced spinal inflammation.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have shed new light on the factors involved in spinal inflammation triggered by human T-lymphotropic virus type I (HTLV-I) infection. ...

Study: Two-dose Zenapax reduced incidence of acute organ rejection.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Two doses of the immunosuppressive agent Zenapax (daclizumab) decreased rejection in kidney transplant patients at high risk for delayed organ function, and had cost benefits when compared with OKT3...

Campath study shows increased life expectancy.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- Life expectancy for heavily pretreated B-cell chronic lymphocytic leukemia (B-CLL) patients, who were subsequently treated with Campath/MabCampath (alemtuzumab), was shown to double, from 8 to 16...

New product approved to prevent bleeding deaths.
June 20, 2002... 2002 JUN 20 - (NewsRx.com & NewsRx.net) -- A razor nick during a much-too-close shave 10 years ago may result in hundreds of thousands of lives saved in the future. Scientist Frank Hursey was working with absorptive materials back in the late...

Bovine hemoglobin-based oxygen carrier safe for surgical use.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that a bovine hemoglobin-based oxygen carrier appears to be suitable for use as a surgical blood substitute. ...

Monocyte activity elevated in patients.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Patients suffering from sickle cell disease (SCD) show heightened levels of monocyte activity, researchers in the United States report. "Tumor necrosis...

Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Procedures used for ridding plasma of viral contaminants may be causing liver transplant recipients to develop hyperfibrinolysis after transplantation. ...

Gene transfer allows earlier use of chemotherapy after marrow procedure.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Patients who initially receive implanted bone marrow cells made resistant to cytotoxicity may see more advantages from subsequent chemotherapy, researchers...

Liposomal daunorubicin encapsulation reduces excessive cytotoxic activity.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United Kingdom have shed new light on the effects of encapsulating the anticancer agent daunorubicin (DNR) in a liposomal coating. Dr....

Mannose-binding lectin replacement may reduce morbidity risk.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia have identified a novel target for treatments aimed at preventing morbidity after hematopoietic stem cell transplantation. ...

DC-SIGN could be therapeutic target.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Spain say that they may have found a novel target for immnotherapy against HIV infection. "Dendritic cell-specific ICAM-3 grabbing...

Frequent cocaine use linked to heart attack, stroke.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Frequent cocaine use triggers a dangerous series of events linked to risk of heart attack and stroke, report McLean Hospital researchers in the May 2002 issue of the American Journal of Cardiology. ...

Interleukin-4 deficits reduce risk.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The cytokine interleukin-4 may contribute to atherosclerosis development when released by blood cells, according to researchers in the United States. ...

Malignant cells can express immunosuppressive enzyme.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia have shed new light on the ability of cancer cells to avoid detection by immune processes. "The mechanisms by which tumor cells...

CRP levels predict risk of sudden death.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Deadly plaques in the arteries can now be identified with a simple blood test, researchers report in one of the first studies of its kind. The study was published in Circulation: Journal of the...

New drug holds promise to block clots.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- The first study of a new drug designed to block blood clot formation showed no major adverse effects in people with stable coronary artery disease, according to a report in Circulation: Journal of the...

Girl apparently cured after first bone marrow transplant of its kind.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- A 6-year-old girl appears cured of her rare blood disease after she received what doctors say is the first bone marrow transplant of its kind in the world. Alicia Woolhiser received a transplant...

NIH grant awarded for the development of a test to detect infectious prion proteins in blood.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., (BBII) has been awarded a phase I Small Business Technology Transfer Grant (STTR) to develop a highly sensitive assay for the detection of prion proteins in blood. This...

Studies: Long-term use CellCept lowers rejection risk.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Long-term (greater or equal to 1 year) use of CellCept (mycophenolate mofetil) reduced the incidence and risk of late rejection of kidney transplants compared with azathioprine, even in high-risk...

Steroid pill prolongs survival.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Researchers at Cedars-Sinai Medical Center report that treatment with a steroid pill improves the overall survival of patients with multiple myeloma, a cancer of the plasma cells in bone marrow. The...

Dendritic cell yields can be improved in culture.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have found a way to improve the amount of antigen-presenting cells derived from hematopoietic stem cell cultures. Dr. Aichun Liu and...

Graft-versus-host prophylaxis improves outcome with depleted grafts.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Extensive graft-versus-host prophylaxis is needed to ensure maximal benefit from T cell-depleted stem cell grafts, researchers in the United States argue. ...

Optimal serum-free expansion conditions identified.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States may have identified the best methods for expanding hematopoietic stem cells in culture using serum-free media. Ronald L....

Photodynamic graft purging helps prevent graft-versus-host reactions.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in North Carolina have developed a novel technique for selectively removing dangerous T cells from stem cell grafts. Dr. Benny J. Chen and...

La Jolla reports new data on antibody-mediated thrombosis.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Co. (LJPC) presented data supportive of its investigational drug candidate LJP 1082 for the treatment of antibody-mediated thrombosis, a life-threatening blood-clotting disorder...

Success of bioengineering of blood vessels lies in 'scaffold,' said scientist.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Blood vessel prostheses work best when the biochemical and mechanical properties match reality as much as possible and when they are made of biodegradable material. To this end tissue technologists...

Parents' blood donations less safe than previously thought.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Parents who donate blood for their children are actually more likely to have their blood rejected by blood donor centers because of higher incidences of infectious disease markers compared with...

Study explores why heart transplant patients resume smoking.
June 27, 2002... 2002 JUN 27 - (NewsRx.com & NewsRx.net) -- Nearly half of exsmokers who receive heart transplants resume smoking at some point after their life-saving operation, and now researchers have good evidence to suggest who is at risk of relapse....